Skip to main content
Signal8

Barry Douglas

SEC insider (Form 3/4/5 filer). CIK 0001890662. General Counsel at Tango Therapeutics, Inc. (TNGX). 3 reported Form 4/5 transactions since Sep 2024; latest on Feb 5, 2025. Located in BOSTON, MA.

Companies Barry Douglas has filed insider reports for

  • Tango Therapeutics, Inc. (TNGX): Officer, General Counsel
Barry Douglas profile photo

Barry Douglas

CIK: 0001890662

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)2 (66.7%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)1 (33.3%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Tango Therapeutics, Inc. logo
TNGX

Tango Therapeutics, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (3 total)

  • Tango Therapeutics, Inc. logo
    TNGX

    Tango Therapeutics, Inc.

    Feb 5, 2025
    Sale
    Direct
    2.6K shares at avg. $3.16$8K
  • Tango Therapeutics, Inc. logo
    TNGX

    Tango Therapeutics, Inc.

    Feb 4, 2025
    Sale
    Direct
    2.8K shares at avg. $2.99$8K
  • Tango Therapeutics, Inc. logo
    TNGX

    Tango Therapeutics, Inc.

    Feb 3, 2025
    Award
    Direct
    27.4K shares-

1-3 of 3